Alzheimer's patients test drug for over a year in extended safety study
Disease control
Terminated
This study aimed to check the long-term safety and effects of an experimental drug called XPro1595 in people with Alzheimer's disease. It was an extension for 11 people who had already taken the drug in an earlier trial. Participants received a weekly injection for up to 18 month…
Phase: PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC